Canaccord Genuity Maintains a 'Buy' on Ameresco (AMRC); Resilient Backlog
Tweet
Share
E-mailGet Alerts AMRC Hot Sheet
Price: $22.36 -11.79%
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 20
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 20
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Ameresco (NYSE: AMRC) price target of $17.00.
Analyst, John Quealy, said, "We maintain our rating, as Ameresco appears well positioned within the $5B energy services market to deliver on its long-term top-/bottom-line growth objective of 15-20% per year...We look for consolidated gross margins to hold relatively steady q/q, with EE at ~19% and Renewable Energy at ~18%, while also expecting ’12 guidance to be affirmed (revenues/net income at $800-825M/$39.5-42.5M, respectively)."
For an analyst ratings summary and ratings history on Ameresco click here. For more ratings news on Ameresco click here.
Shares of Ameresco closed at $11.83 yesterday.
Analyst, John Quealy, said, "We maintain our rating, as Ameresco appears well positioned within the $5B energy services market to deliver on its long-term top-/bottom-line growth objective of 15-20% per year...We look for consolidated gross margins to hold relatively steady q/q, with EE at ~19% and Renewable Energy at ~18%, while also expecting ’12 guidance to be affirmed (revenues/net income at $800-825M/$39.5-42.5M, respectively)."
For an analyst ratings summary and ratings history on Ameresco click here. For more ratings news on Ameresco click here.
Shares of Ameresco closed at $11.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nutanix (NTNX) PT Raised to $80 at Oppenheimer Into EPS
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Jefferies Downgrades IDP Education (IEL:AU) (IDPUF) to Hold
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
